Quest diagnostics completes acquisition of haystack oncology, adding sensitive mrd liquid biopsy technology to cancer diagnostics portfolio

Secaucus, n.j. , june 21, 2023 /prnewswire/ -- quest diagnostics (nyse:dgx), the nation's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of haystack oncology.
DGX Ratings Summary
DGX Quant Ranking